Inside WeightWatchers’ Bold Pivot To Dominate The Ozempic Era

WeightWatchers’ bold gamble: CEO Sistani fuses AI, GLP-1 drugs, and 60 years of trust into a revolutionary health tech platform to conquer the $377B weight loss market.


Source link